Mayo Clinic Sorrento Therapeutics, Inc. Transaction History

Mayo Clinic

  • $2.72 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$6.35 - $10.0 $2.16 Million - $3.4 Million
-339,842 Reduced 53.11%
300,000 $2.91 Million
Q1 2021

May 13, 2021
SELL
$7.03 - $16.51 $126,786 - $297,757
-18,035 Reduced 2.74%
639,842 $5.29 Billion
Q4 2020

Feb 11, 2021
BUY
$5.76 - $11.95 $3.79 Million - $7.86 Million
657,877 New
657,877 $4.49 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Mayo Clinic Portfolio

Follow Mayo Clinic and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayo Clinic, based on Form 13F filings with the SEC.

News

Stay updated on Mayo Clinic with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email